फैबटेक टेक्नोलॉजीज़ IPO अलॉटमेंट स्टेटस कैसे चेक करें?

Fabtech Technologies Limited is a biopharma engineering company designing and delivering turnkey projects including cleanroom facilities, modular systems, and customized engineering solutions, incorporated in 2018, providing end-to-end services encompassing design, engineering, manufacturing, installation, and project management with expertise in cleanroom technology, HVAC systems, and process equipment serving global clients ensuring compliance with international regulatory standards, offering comprehensive services spanning complete bio-pharma manufacturing life cycle from direction setting through product market launch, clean water solutions providing equipment for purified water, pure steam generation and distribution, and water for injections with flow rates ranging from 500 LPH to 50,000 LPH, and clean air solutions supporting life sciences, food and beverage, IT, semiconductor, and aeronautics industries with innovative applications, maintaining in-house software technology capabilities, diversified order book across geographies and business verticals, efficient lead funneling with higher mandate conversion, experienced leadership team with Fabtech Group parentage, employing 185 permanent employees as of July 31, 2025.

The Fabtech Technologies IPO came with a total issue size of ₹230.35 crore, comprising entirely a fresh issue of 1.21 crore shares aggregating to ₹230.35 crore. The IPO opened on September 29, 2025, and closed on October 1, 2025. The allotment for the Fabtech Technologies IPO is expected to be finalized on Friday, October 3, 2025. The Fabtech Technologies IPO share price band was set at ₹181 to ₹191 per share.

अगला बड़ा IPO न भूलें - बस कुछ क्लिक में इन्वेस्ट करें!

अभी अकाउंट खोलें

रजिस्ट्रार साइट पर फैबटेक टेक्नोलॉजीज़ IPO आवंटन की स्थिति चेक करने के चरण

• बिगशेयर सर्विसेज़ प्राइवेट लिमिटेड पर जाएं. वेबसाइट
• अलॉटमेंट स्टेटस पेज पर ड्रॉपडाउन मेनू से "फैबटेक टेक्नोलॉजीज़" चुनें
• निर्धारित फील्ड में अपनी पैन आईडी, डीमैट अकाउंट नंबर या एप्लीकेशन नंबर दर्ज करें
• कैप्चा वेरिफिकेशन प्रोसेस पूरा करें और अपना अलॉटमेंट स्टेटस देखने के लिए "सबमिट करें" बटन पर क्लिक करें

BSE पर फैबटेक टेक्नोलॉजीज़ IPO अलॉटमेंट स्टेटस चेक करने के चरण

• BSE SME IPO अलॉटमेंट स्टेटस पेज पर जाएं
• समस्या का प्रकार चुनें: इक्विटी/डेट
• ड्रॉपडाउन मेनू में ऐक्टिव IPO की लिस्ट में से "फैबटेक टेक्नोलॉजी" चुनें
• आवश्यक फील्ड में अपना एप्लीकेशन नंबर और PAN ID दर्ज करें
• कैप्चा वेरिफाई करें और अपना अलॉटमेंट स्टेटस चेक करने के लिए "खोजें" पर क्लिक करें

फैबटेक टेक्नोलॉजीज़ IPO सब्सक्रिप्शन स्टेटस

फैबटेक टेक्नोलॉजीज़ IPO को मध्यम निवेशक ब्याज मिला, जिसे कुल मिलाकर 2.04 गुना सब्सक्राइब किया जा रहा है. The subscription showed balanced confidence with consistent participation across all categories. अक्टूबर 1, 2025 को 5:04:43 PM तक सब्सक्रिप्शन की कैटेगरी के अनुसार विवरण यहां दिया गया है:

• नॉन-इंस्टीट्यूशनल इन्वेस्टर (एनआईआई): 1.97 बार.
• क्यूआईबी कैटेगरी (एक्स एंकर): 2.02 बार.
• रिटेल इन्वेस्टर: 2.09 बार.
• कर्मचारी: 2.01 बार.

Fabtech Technologies IPO Share Price and Investment Details

The Fabtech Technologies IPO stock price band was set at ₹181 to ₹191 per share with a minimum lot size of 75 shares. 1 लॉट (75 शेयर) के लिए रिटेल इन्वेस्टर के लिए न्यूनतम इन्वेस्टमेंट ₹14,325 था. The issue included up to 54,945 shares reserved for employees at discount of ₹9.00 per share. Given the moderate subscription response of 2.04 times overall, with balanced institutional interest at 2.02 times, consistent NII participation at 1.97 times, solid retail subscription at 2.09 times, and strong employee participation at 2.01 times, the Fabtech Technologies IPO share price is expected to list with modest premium.

IPO आय का उपयोग

IPO के माध्यम से जुटाए गए फंड का उपयोग इस प्रकार किया जाएगा:

• कार्यशील पूंजी की आवश्यकताओं के लिए फंडिंग: ₹ 127.00 करोड़.
• Pursuing inorganic growth initiatives through acquisitions: ₹30.00 crore.
• सामान्य कॉर्पोरेट उद्देश्य: शेष राशि.

बिज़नेस ओवरव्यू

Fabtech Technologies Limited operates as key turnkey engineering solution provider offering integrated solutions with comprehensive service offerings under one roof for global customers in pharma, biotech, and healthcare sectors, in-house software technology capabilities, diversified order book across geographies, clients, and business verticals, proven project execution capabilities across diverse and challenging geographies, efficient lead funneling resulting in higher mandate conversion, track record of executing projects across all dosage forms, and experienced leadership team with Fabtech Group parentage while demonstrating strong financial performance with 46% revenue increase and 70% PAT rise between FY24-FY25, maintaining healthy financial metrics with 30.46% ROE, strong 13.83% PAT margin, and moderate debt-equity ratio of 0.32. The company enjoys specialized positioning in turnkey engineering solutions for biopharma sector with comprehensive capabilities from design through execution, positioned to benefit from India's expanding pharmaceutical manufacturing sector and increasing global demand for compliant cleanroom facilities.